USPRX
Price
$91.11
Change
-$0.74 (-0.81%)
Updated
Jul 13 closing price
Net Assets
15.56B
VTSAX
Price
$179.98
Change
-$1.44 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

USPRX vs VTSAX

USPRX vs VTSAX Comparison Chart in %
View a ticker or compare two or three
VS
USPRX vs. VTSAX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is USPRX is a Hold and VTSAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 2.3T vs. USPRX (15.6B). VTSAX pays higher dividends than USPRX: VTSAX (1.04) vs USPRX (0.88). USPRX was incepted earlier than VTSAX: USPRX (24 years) vs VTSAX (26 years). USPRX (0.19) is less costly to investors than VTSAX (0.04). VTSAX is a more actively managed with annual turnover of: 3.00 vs. USPRX (2.00). VTSAX has a lower initial minimum investment than USPRX: VTSAX (3000) vs USPRX (100000). VTSAX annual gain was more profitable for investors over the last year : 21.47 vs. USPRX (18.63). VTSAX (66.46) and USPRX (63.61) have equivalent 5 years return.
USPRXVTSAXUSPRX / VTSAX
Total Expense Ratio0.150.04375%
Annual Report Gross Expense Ratio0.190.04475%
Fund Existence24 years26 years-
Gain YTD11.49311.207103%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets15.6B2.3T1%
Annual Yield % from dividends0.881.0484%
Returns for 1 year18.6321.4787%
Returns for 3 years64.7567.0097%
Returns for 5 years63.6166.4696%
Returns for 10 years229.64250.4892%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CEMVX18.58N/A
N/A
Causeway Emerging Markets Investor
GSMYX25.93N/A
N/A
Goldman Sachs Small/Mid Cap Growth Instl
VGSIX32.36N/A
N/A
Vanguard Real Estate Index Investor
TBWCX21.92N/A
N/A
Thornburg Better World International C
MCYVX16.17-0.50
-3.00%
NYLI Candriam Emerging Markets Eq Inv Cl